FSD Pharma Inc. | WebDisclosure

Basculer en Français

8641	Companies
145308	Keywords
81045	Articles
77781	Press releases

Home
Companies
FSD Pharma Inc.

PRESS RELEASE

published on 02/26/2024 at 14:00, 1 year 2 months ago

FSD Pharma Signs Agreement With Ingenu CRO to Conduct a Clinical Trial To Determine the Safety and Efficacy Effects of its Proprietary Blend Beverage unbuzzd(TM)
FSD Pharma Inc. announced an agreement for a clinical trial to test unbuzzd™ effects on faster alcohol metabolism. The trial aims to confirm the supplement's potential benefits in sobering up from alcohol intoxication

FSD Pharma Inc. Biopharmaceutical Clinical Trial Unbuzzd™ Alcohol Metabolism
BRIEF

published on 02/26/2024 at 14:00, 1 year 2 months ago

FSD Pharma launches a clinical trial to test the effectiveness of unbuzzd™

FSD Pharma Clinical Test Unbuzzd™ Alcohol Metabolism Accelerated Sobriety
BRIEF

published on 02/26/2024 at 14:00, 1 year 2 months ago

FSD Pharma lance un essai clinique pour tester l'efficacité d'unbuzzd™

FSD Pharma Essai Clinique Unbuzzd™ Métabolisme De L'alcool Sobriété Accélérée
PRESS RELEASE

published on 02/17/2024 at 01:10, 1 year 2 months ago

FSD Pharma Announces US ATM Offering
FSD Pharma announces an at-the-market offering agreement with H.C. Wainwright & Co., LLC to sell Class B Shares for up to US$11,154,232. The Company may use proceeds for clinical trials & general corporate purposes

FSD Pharma Biopharmaceutical At-the-market Offering H.C. Wainwright & Co. Class B Shares
PRESS RELEASE

published on 02/06/2024 at 13:00, 1 year 2 months ago

Court of Appeal Dismisses Motion for Leave to Appeal Brought by Dr. Raza Bokhari, FSD Pharma Awards Total Approximately $3 Million
FSD Pharma Inc. announced that the Court of Appeal for Ontario affirmed the Judgment entered by the Superior Court of Justice. The company also filed a Petition to Confirm Arbitration Awards in the United States District Court for the Eastern District of Pennsylvania

FSD Pharma Inc. Court Of Appeal Biopharmaceutical Arbitration Awards Neurodegenerative Disorders
PRESS RELEASE

published on 01/29/2024 at 22:30, 1 year 3 months ago

FSD Pharma Announces Dr. Sanjiv Chopra is elected to FSD Pharma Board of Directors and Corporate Updates
FSD Pharma appoints Dr. Sanjiv Chopra to its board of directors, replaces Nitin Kaushal. Also, the company retains SBS Intl Group LLC, Draper Inc., Carriage House Capital, Corp., IR Agency, Beyond Media, Issuer Direct for various services. FSD focuses on biopharmaceutical assets

FSD Pharma Dr. Sanjiv Chopra Biopharmaceutical SBS Intl Group LLC IR Agency
PRESS RELEASE

published on 01/16/2024 at 13:30, 1 year 3 months ago

Update Provided on GBB Drink Lab, Inc. Litigation and Safety Shot
FSD Pharma Inc., a biopharmaceutical company, provides an update on its litigation with GBB Drink Lab, Inc., denying allegations and moving for discovery. The company remains confident in its legal position and looks forward to vindicating its rights and exposing GBB and its bully tactics.

Biopharmaceutical Company FSD Pharma Inc. Litigation Update GBB Drink Lab Inc. Alcohol Detoxification
PRESS RELEASE

published on 12/23/2023 at 01:45, 1 year 4 months ago

FSD Pharma Files Final Base Shelf Prospectus to Replace Expired Base Shelf Prospectus and Form F-3 Registration Statement with the SEC
PRESS RELEASE

published on 12/05/2023 at 15:00, 1 year 4 months ago

FSD Pharma Inc. Announces Closing of Private Placement
FSD Pharma Inc. announces the closing of private placement and issuance of class A multiple voting shares at $1.90 per share for gross proceeds of $45.60. The proceeds will be used for general working capital purposes

Private Placement FSD Pharma Inc. Financial News Investment Class A Multiple Voting Shares
PRESS RELEASE

published on 11/30/2023 at 14:30, 1 year 5 months ago

FSD Pharma Inc. and Celly Nutrition Corp. Announce Completion of Plan of Arrangement
FSD Pharma Inc. and Celly Nutrition Corp. announce completion of Plan of Arrangement including distribution of Celly Nu Shares and New FSD Pharma Securities to FSD Pharma securityholders

FSD Pharma Inc. Plan Of Arrangement Celly Nutrition Corp. Celly Nu Shares New FSD Pharma Securities

Accesswire

Published on 05/02/2025 at 13:45, 39 minutes ago

Presidential Endorsement and OTCQB Listing t
Published on 05/02/2025 at 13:30, 54 minutes ago

Jericho Energy Ventures' AI Data Center Sites Favorably Positioned on Major U.S. Fiber Route
Published on 05/02/2025 at 13:00, 1 hour 24 minutes ago

Irving Resources Reports Change of Chief Financial Officer
Published on 05/02/2025 at 12:30, 1 hour 54 minutes ago

SouthGobi Announces the Date of Board Meeting
Published on 05/02/2025 at 05:00, 9 hours 24 minutes ago

NexOptic Technology Corp. Announces Delay in Filing 2024 Annual Financial Statements

View all ACCESSWIRE

EQS Group

Published on 05/02/2025 at 13:15, 1 hour 9 minutes ago

DN Deutsche Nachhaltigkeit: EasyMotion investment achieves high ESG scoring of 48 points
Published on 05/02/2025 at 12:58, 1 hour 25 minutes ago

MEDICLIN increases group operating result in the first quarter of 2025
Published on 05/02/2025 at 12:30, 1 hour 54 minutes ago

Immunic to Participate in Scientific and Industry Conferences in May
Published on 05/02/2025 at 11:31, 2 hours 52 minutes ago

Les incertitudes freinent le marché automobile
Published on 05/02/2025 at 11:26, 2 hours 57 minutes ago

Einhell: Record revenue and earnings in financial year 2024

Les Echos

Published on 04/30/2025 at 20:31, 1 day 17 hours ago

COMMUNIQUE DE PRESSE - RESULTATS 2024
Published on 04/30/2025 at 19:14, 1 day 19 hours ago

Report de la publication des résultats annuels 2024
Published on 04/30/2025 at 19:14, 1 day 19 hours ago

Solocal - Press Release - Filing of 2024 URD
Published on 04/30/2025 at 19:14, 1 day 19 hours ago

Solocal - Communiqué de presse - Mise à disposition du DEU 2024
Published on 04/30/2025 at 18:55, 1 day 19 hours ago

Access to information in respect of the General Shareholders’ Meeting to be held on June 5, 2025

View all LES ECHOS COMFI WIRE